AGM/EGMMay 28, 2026, 04:51 PM
Regentis Biomaterials Schedules AGM for July 2, 2026
AI Summary
Regentis Biomaterials Ltd. announced its Annual General Meeting (AGM) of shareholders to be held on July 2, 2026, in Tel Aviv, Israel. The agenda includes the re-election of Dr. Ehud Geller and Mr. Efraim Cohen-Arazi to the Board of Directors, approval of option grants to serving directors and a top-up grant to Mr. Pini Ben-Elazar, and the issuance of warrants to Dr. Ehud Geller and Mr. Jeff Dykan. Additionally, shareholders will vote on the adoption of the Company's Compensation Policy and the re-appointment of Deloitte Israel & Co. as the independent auditors for the fiscal year ending December 31, 2026.
Key Highlights
- Annual General Meeting (AGM) scheduled for Thursday, July 2, 2026, at 3:00 p.m. Israel Time.
- Shareholders to vote on re-election of Dr. Ehud Geller and Mr. Efraim Cohen-Arazi as Class I directors.
- Approval sought for grant of 24,826 options to each of Mr. Jeff Dykan, Mr. Keith Valentine, and Mr. Efraim Cohen-Arazi.
- Shareholders to approve a top-up grant of 8,313 fully vested options to Mr. Pini Ben-Elazar at NIS 0.01 exercise price.
- Approval requested for issuance of warrants to Dr. Ehud Geller (31,250 shares) and Mr. Jeff Dykan (12,500 shares) at NIS 0.01 exercise price.
- Adoption of the Company's Compensation Policy in accordance with Israeli Companies Law to be voted on.
- Re-appointment of Deloitte Israel & Co. as independent registered public accounting firm for 2026.
- Review and discussion of financial statements for the year ended December 31, 2025.
Price Impact
More from RGNT